Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DEWEY

Showing results (421-430 of 460) with videos related to

Pageof 46
Sort By:
Journal of Medicinal Chemistry|February 1, 1979
Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotineM D Aceto, B R Martin, I M Uwaydah, et al.
Journal of Medicinal Chemistry|February 10, 2009
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonistsGuo Li, Lindsey C Aschenbach, Jianyang Chen, et al.
Psychopharmacology|February 25, 2022
Opioid-like adverse effects of tianeptine in male rats and miceT R Baird, H I Akbarali, W L Dewey, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high"N D Volkow, G J Wang, J S Fowler, et al.
British Journal of Pharmacology|March 25, 2009
Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neuronsC P Bailey, S Oldfield, J Llorente, et al.
The American Journal of Psychiatry|April 1, 1997
Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjectsG S Smith, S L Dewey, J D Brodie, et al.
Synapse (New York, N.Y.)|September 2, 1998
A novel strategy for the treatment of cocaine addictionS L Dewey, A E Morgan, C R Ashby, et al.
Journal of Medicinal Chemistry|December 29, 2023
Molecular Pharmacology Profiling of Phenylfentanil and Its Analogues to Understand the Putative Involvement of an Adrenergic Mechanism in Fentanyl-Induced Respiratory DepressionMengchu Li, Piyusha P Pagare, Hongguang Ma, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PETC Y Shiue, L Q Bai, R R Teng, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1992
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomographyS L Dewey, G S Smith, J Logan, et al.
Pageof 46

Showing results (421-430 of 460) with videos related to

Sort By:
Pageof 46
Journal of Medicinal Chemistry|February 1, 1979
Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotineM D Aceto, B R Martin, I M Uwaydah, et al.
Journal of Medicinal Chemistry|February 10, 2009
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonistsGuo Li, Lindsey C Aschenbach, Jianyang Chen, et al.
Psychopharmacology|February 25, 2022
Opioid-like adverse effects of tianeptine in male rats and miceT R Baird, H I Akbarali, W L Dewey, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high"N D Volkow, G J Wang, J S Fowler, et al.
British Journal of Pharmacology|March 25, 2009
Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neuronsC P Bailey, S Oldfield, J Llorente, et al.
The American Journal of Psychiatry|April 1, 1997
Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjectsG S Smith, S L Dewey, J D Brodie, et al.
Synapse (New York, N.Y.)|September 2, 1998
A novel strategy for the treatment of cocaine addictionS L Dewey, A E Morgan, C R Ashby, et al.
Journal of Medicinal Chemistry|December 29, 2023
Molecular Pharmacology Profiling of Phenylfentanil and Its Analogues to Understand the Putative Involvement of an Adrenergic Mechanism in Fentanyl-Induced Respiratory DepressionMengchu Li, Piyusha P Pagare, Hongguang Ma, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PETC Y Shiue, L Q Bai, R R Teng, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1992
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomographyS L Dewey, G S Smith, J Logan, et al.
Pageof 46